Azacitidine Plus Deferasirox (ICL670) in Higher Risk Myelodysplastic Syndromes (MDS)
Clinical trial NCT02038816 · TERMINATED
Trial details
- NCT number
- NCT02038816
- Sponsor
- Sunnybrook Health Sciences Centre
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2016-09-29
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.